Adenosine diphosphate (ADP), an endogenic agent released by platelets, erythrocytes, and endothelial cells, 10 relaxes blood vessels by an endotheliumdependent mechanism.
T he relaxing effect of endothelium by vasoactive agents has been extensively studied as a modulating factor in vascular responses. 1 " 9 Adenosine diphosphate (ADP), an endogenic agent released by platelets, erythrocytes, and endothelial cells, 10 relaxes blood vessels by an endotheliumdependent mechanism.
11
" 17 It is now evident that nitric oxide produced by endothelial cells accounts for the endothelium-dependent vascular relaxations 1518 " 20 through stimulation of soluble guanyl-ate cyclase. 118 " 22 Endogenous vasoconstrictors, such as norepinephrine, release nitric oxide in the endothelial cells, which, in turn, acts as a physiological antagonist in the arterial smooth muscle. 3 -15 These agents have a much greater maximum efficacy as vasoconstrictors in the absence of endothelium. 6 ' 7 Alterations in endothelial integrity or reduced endothelial response could be responsible for the increased reactivity of isolated vessels in arterial hypertension. Reduced endothelium-dependent relaxations induced by acetylcholine in genetic, deoxycorticosterone acetate-salt, and renovascular models of experimental hypertension are in agreement with the idea that the reduction or inhibition of the continuous release of nitric oxide could contribute to hypertension. 491719 - 23 - 29 The present study was designed to investigate the effect of ADP on responses of the mesenteric vascuby guest on July 12, 2017 http://hyper.ahajournals.org/ lar bed (MVB) from normotensive and renovascular hypertensive rats to norepinephrine.
TABLE 1. Responses of Isolated Perfused Mesenteric Vascular Bed From Normotenslve and Hypertensive Rats to Norepinephrine Before and After Removal of Endothdinm

With endothelium
Control
Methods
Experimental Animals
Male Wistar rats (220-350 g) supplied by the breeding unit of the Cardiovascular Laboratory (Department of Physiological Sciences, Biomedical Center, Universidade Federal do Espi'rito Santo) were used for studies on isolated MVB.
Renovascular Hypertension and Normotensive Controls
With rats under ether anesthesia, renovascular hypertension (Goldblatt one-kidney, one clip [1K1C] model) was obtained by placing a preset U-shaped silver clip (0.2-mm i.d.) around the left renal artery, combined with nephrectomy of the right kidney through a median abdominal incision. Weight-matched controls were sham-operated rats submitted to right-sided nephrectomy (SON). After the procedures, the muscle layers were reconnected and the skin incision closed. Rats were then allowed to recover in their cages with free access to normal food and water.
Hemodynamic Measurements
Blood pressure measurements were recorded directly through an indwelling catheter. A polyethylene catheter (PE-50 with tapered end) filled with heparinized saline (40 units/ml) was placed in the abdominal aorta through the femoral artery with rats under ether anesthesia. The catheter was tunneled subcutaneously and brought to the exterior at the dorsal midcervical region of the neck. Mean arterial pressure and heart rate were recorded in the conscious, unrestrained animals 6 hours later. The arterial catheter was connected to a 1280C pressure transducer by a flexible connecting tubing, and mean arterial pressure was continuously recorded on a polygraph (7754B, Hewlett-Packard Co., Palo Alto, Calif.). Heart rate was computed from the arterial pressure pulse waves.
Isolated Perfused Mesenteric Vascular Bed
The MVB was prepared for perfusion essentially according to McGregor. 29 Briefly, rats were given heparin (Roche, 1,000 units •kg"') subcutaneously, and the proximal end of the superior mesenteric artery was cannulated with rats under ether anesthesia. The associated vascular bed was perfused with a warmed (37°C) physiological saline solution at a constant flow rate of 4 ml • min"
1 by means of a roller pump (BP-100, Incibr£s, Sao Paulo, Brazil). The physiological saline solution, gassed with a mixture of 95% O2-5% CO2, had the following composition ( 
FIGURE 1. Lin« graphs show contractions induced by norepinephrine in isolated perfused vascular bed with and without endothelium from normotensive (SON, n=18) and renovascular hypertensive (1K1C, n=18) rats in the absence and presence of adenosine diphosphate (ADP, 2xlO~6M, added toperfusion fluid). Ordinate scales are logarithmic. Values are mean±SEM. Left panel: With intact endothelium, contractions induced by norepinephrine are significantly increased in 1K1C rats at doses of 4.0, 16.0 (p<0.05), and 64.0 fig (p<0.01). Presence of ADP significantly decreased (p<0.01) contractions to norepinephrine in both normotensive (SON+ADP) and hypertensive (1K1C+ADP) rats. Right panel: Without endothelium, contractions to norepinephrine were not significantly different in both groups of animals. Presence of ADP did not change the pattern of contractions.
stopping the blood supply and starting perfusion with the solution did not exceed 1 minute. The whole mesentery was carefully removed, placed into saline, dissected from the associated bowels, cleaned of adhering lymphatic tissue, and placed in an organ bath. Changes in perfusion pressure were measured with the 1280C pressure transducer placed close to the end of the outflow cannula and were recorded on the 7754B polygraph. Zero pressure was calibrated to zero flow. Because the perfusion rate was constant, changes in perfusion pressure could be directly related to changes in vascular resistance. Basal perfusion pressure was allowed to stabilize, and the perfused MVB was subjected to administration of norepinephrine bitartrate (Sigma Chemical Co., St. Louis, Mo.).
Norepinephrine Administration
Thirty minutes after stabilization of basal perfusion pressure and at intervals of 10 minutes, bolus injections of norepinephrine were done. The following doses were administered in fixed volumes of 0. 
Manipulations
Responses of the MVB from hypertensive 1K1C and SON rats to norepinephrine were tested during four manipulations.
Treatment with ADP. Responses of the MVB to injections of norepinephrine in the presence of ADP (Sigma) were obtained by adding this nucleotide to the solution to give a final concentration of 2x 10~6 M.
Endothelium removal Removal of the endothelium was achieved by perfusion of the MVB with the nonionic, nondenaturing detergent 3-[(3-cholamidopropyl)dimethylammonio]-l-propanesulfonate (CHAPS, Sigma) at 0.3% (wt/vol) for 60 seconds followed by a 45-minute reequilibration period. 6 The presence of functional endothelium was tested by bolus injections of single combined doses of acetylcholine chloride (Sigma) (100 ng) plus norepinephrine (16.0 /xg) before and after CHAPS.
nine (L-NOARG, Sigma) was added to the perfusion fluid to give a final concentration of 5xlO~5 M and was perfused during 15 minutes. 25 A 15-minute equilibration period was observed before administration of norepinephrine.
Treatment with methylene blue. Responses of the MVB to norepinephrine were obtained 10 minutes after a 15-minute perfusion with methylene blue (MB, E. Merck AG, Darmstadt, FRG) added to the solution to give a final concentration of 5 x 10" 5 M. 6 
Data Analysis and Statistics
All data are reported as mean±SEM. One-way and two-way analyses of variance were used in comparisons. 
Results
Mean Arterial Pressure, Heart Rate, and Basal Perfusion Pressure
Mean arterial pressure and heart rate were significantly higher (p<0.0l) in 1K1C (153±3 mm Hg and 383 ±7 beats per minute, respectively, n=32) than in SON (111±1 mmHg and 335±4 beats per minute, respectively, n=32) animals. During the experiments, basal perfusion pressure remained stable, at approximately 40 mm Hg, and was similar for both normotensive SON and hypertensive 1K1C animals.
Reactivity of Mesenteric Arteries to Norepinephrine
In mesenteric arteries with endothelium, injections of norepinephrine evoked significantly greater contractions (p<0.01, one-way analysis of variance) in 1K1C than in SON rats at all norepinephrine doses. Removal of endothelium increased the contractions (/><0.01, one-way analysis of variance) in both normotensive and hypertensive rats at all norepinephrine doses (Table 1) . With intact endothelium, treatment with L-NOARG significantly increased (/?<0.01, one-way analysis of variance) responses to norepinephrine at all doses in SON rats but not in 1K1C rats as compared with their respective controls. Treatment with L-NOARG after endothelium removal did not change the pattern of contractions obtained after this same treatment with intact endothelium (Table 1) . With intact endothelium, treatment with MB caused the greatest increases (p<0.0\, one-way analysis of variance) in responses to norepinephrine. These increases were observed at all norepinephrine doses in both SON and 1K1C rats. Treatment with MB after removal of endothelium did not cause significant changes in contractions compared with those obtained after the same treatment with intact endothelium (Table 1) .
Effects of Adenosine Diphosphate
With intact endothelium, the presence of ADP significantly decreased (p<0.01, one-way analysis of variance) the responses for all norepinephrine doses in both SON and 1K1C rats (Figure 1, left panel) . The decreases ranged from 65% to 75% in SON and from 51% to 73% in 1K1C rats and were smaller in 1K1C than in SON rats from the third to fifth norepinephrine dose ( Table 2) . Effects of ADP were completely prevented in both groups of animals after removal of endothelium ( Figure 1, right panel) . With intact endothelium, decreases caused by ADP after treatment with L-NOARG were not statistically significant. However, a tendency to decreased responses at all norepinephrine doses was observed in both SON and 1K1C rats. Thus, it appears that L-NOARG diminishes but does not completely prevent the effect of ADP (Table 2) . This tendency to decreased responses 
M, intraluminally perfused) on contractions induced by norepinephrine in isolated perfused mesenteric vascular bed with and without endothelium from nonnotensive (SON, n=6) and renovascular hypertensive (1K1C, n=6) rats in the absence and presence of adenosine diphosphate (ADP, 2xlO~* M, added to perfusion fluid). Ordinate scales are logarithmic. Values are mean±SEM. Contractions induced by norepinephrine did not show significant differences between nonnotensive and hypertensive animals in preparations both with (left panel) and without (right panel) endothelium.
was not observed after removal of endothelium (Figure 2, right panel) . With intact endothelium, treatment with MB partially inhibited the effect of ADP on responses to norepinephrine in SON rats (Figure 3 , left panel). Significant decreases were observed at doses of 16.0 (32%) and 64.0 (40%) fig (Table 2) . These decreases were not observed after removal of endothelium. Although ADP caused no statistically significant changes in responses in the vessels without endothelium after treatment with MB, a tendency to increased responses was observed (Table 2) .
Discussion
The present study demonstrates that under stimulus by ADP the endothelium of resistance arteries of the isolated MVB from nonnotensive and hypertensive rats mediates an important inhibitory effect on norepinephrine-induced contractions. Decreases in responses to norepinephrine by ADP were prevented by removal of endothelium. Thus, ADP exerts its relaxant effect through an action on endotheliaJ cells. Although decreases caused by ADP in the vessels with endothelium after treatment with L-NOARG were not statistically significant, a tendency to decreased responses at all norepinephrine doses seems to suggest that L-NOARG, a potent inhibitor of endothelial nitric oxide formation from the L-arginine pathway, 26 diminishes but does not completely prevent the effect of ADP in mesenteric vessels. Thus, endothelium-dependent decreases in the norepinephrine-induced responses produced by ADP probably are partially dependent on the production of nitric oxide by endothelial cells. As a physiological antagonist of the contracting effect of norepinephrine, the effect of nitric oxide on blood vessels has been shown to be mediated by increasing rates of cyclic GMP production in vascular smooth muscle. 1519 Reduction in the decreases produced by ADP after treatment with MB, an inhibitor of vasodilation to nitric oxide through inhibition of soluble guanylate cyclase, 30 confirms that this agent inhibits endothelium-dependent relaxation in the isolated MVB. On the other hand, the greater increase of the responsiveness in the vessels of the splanchnic circulation after MB points to the relevance of soluble guanylate cyclase in the regulation of systemic arterial pressure. The smaller decreases produced by ADP in the vessels with endothelium from 1K1C rats after MB (Figure 3 , left panel) may be due to a functional impairment of endothelium related to soluble guanylate cyclase activity, causing a decrease in the production of cyclic GMP. 24 It is of interest that the inhibition of endothelium-dependent relaxation related to the inhibition of soluble guanylate cyclase could contribute to arterial hypertension. The tendency to reduction of the endothelium-dependent effect of ADP when nitric oxide formation is inhibited seems to indicate that the ADP-induced relaxation may be due to an interaction with the endothelium in which at least two different relaxing factors are released. One of these is nitric oxide, which ultimately acts to increase the production of cyclic GMP. The endothelium-dependent ADP-induced relaxing effect that appears to remain after treatment with L-NOARG may be related to a second factor distinct from nitric oxide. Data not concluded from our laboratory based on treatment with indomethacin (5xlO~5 M) intraluminally perfused under conditions mentioned in this article seem to exclude a contribution of prostacyclin in the ADP-induced relaxations of the MVB. This also agrees with data from others 25 on acetylcholine-induced relaxations. The tendency to increased responses produced by ADP in vessels without endothelium after MB (Figure 3 , right panel) seems to indicate a direct contracting effect of ADP, which is synergic with that of norepinephrine. This suggests that in the absence (or impairment) of functional integrity of endothelium with a concomitant decrease in the production of nitric oxide and cyclic GMP, ADP could contribute to increase the maximum efficacy of norepinephrine as a vasoconstrictor. In the intact animal, ADP, which acts on endothelial cells and platelet purinergic receptors, is released from platelets, erythrocytes, and endothelial cells. 10 -31 ADP, the main relaxant mediator released from activated platelets, 11 may be important in platelet-vessel wall interaction. In this process, ADP released and inactivated (by ADPases of the endothelial cells) in the immediate vicinity of the effector cells could contribute as a chemical transmitter that stimulates the endothelium-dependent modulation of the final responses to vasoconstrictor stimuli. In this model, the ADP content of erythrocytes and endothelial cells, in addition to the platelet-dense granule content, all constitute a pool of releasable ADP. 31 As blood is forced through vessels with atherosclerotic stenosis or spasm, which induces high shearing forces, platelets are activated. 32 In experiments in which the blood is sheared for many seconds, ADP is usually released from platelets, erythrocytes, or both. Such a release may occur before or after platelet aggregation. 31 These considerations, besides explaining the aggregating and antiaggregating effects of vasoconstrictor and vasodilator agents, respectively, contribute to clarifying the possible mechanism of ADP release in states of increased peripheral vascular resistance, such as arterial hypertension. In this view, ADP could play a role in counteracting the actions of norepinephrine and other vasoconstrictor agents.
